• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏淀粉样变性患者的心电图检查结果。

The findings of electrocardiography in patients with cardiac amyloidosis.

作者信息

Cheng Zhongwei, Zhu Kongbo, Tian Zhuang, Zhao Dachun, Cui Quancai, Fang Quan

机构信息

Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Ann Noninvasive Electrocardiol. 2013 Mar;18(2):157-62. doi: 10.1111/anec.12018. Epub 2012 Nov 22.

DOI:10.1111/anec.12018
PMID:23530486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6932432/
Abstract

OBJECTIVE

The electrocardiography (ECG) was the simplest and common adjunctive diagnostic tool for cardiac amyloidosis (CA). We sought to clarify the findings of ECG in patients with CA in order to early identification of CA according to the findings of ECG.

METHODS

A total of 276 patients with diagnosis of systemic amyloidosis admitted to Peking Union Medical College Hospital from January 2000 to December 2011, were enrolled. Two groups were classified according to the cardiac involvement or not, namely CA (n = 189) and control (n = 87) groups. The low voltage on limb leads defined by the amplitude of the QRS complex in each limb leads ≤0.5 mV. The pseudo-infarct pattern defined by the presence of pathologic Q waves on at least two contiguous leads on ECG without obstructive coronary artery disease.

RESULTS

The mean age was 55 ± 12 (15-88) years, 168 patients (61%) were male. Atrial arrhythmia (15.9% vs 3.4%, P = 0.003), low voltage on limb leads (54.5% vs 20.7%, P < 0.001), atrioventricular block (14.8% vs 1.1%, P = 0.001) and pseudo-infarct pattern (40.2% vs 4.6%, P < 0.001) were more prevalent in CA than control groups. The combination of low voltage on limb leads and pseudo-infarct pattern was more common (28.0% vs 2.3%, P < 0.001) in CA than control groups. The sensitivity, specificity, positive and negative predictive values of the presence of low voltage on limb leads and pseudo-infarct pattern for the diagnosis of CA were 28%, 98%, 96%, and 39%, respectively.

CONCLUSION

In CA patients, low voltage on limb leads and pseudo-infarct pattern were the most common ECG findings. Atrial arrhythmia and atrioventricular block were the most common arrhythmias in CA patients. The combination of low voltage on limb leads and pseudo-infarct pattern had high specificity and positive predictive value for the diagnosis of CA.

摘要

目的

心电图(ECG)是心脏淀粉样变性(CA)最简单且常用的辅助诊断工具。我们试图阐明CA患者的心电图表现,以便根据心电图结果早期识别CA。

方法

纳入2000年1月至2011年12月在北京协和医院确诊为系统性淀粉样变性的276例患者。根据是否有心脏受累分为两组,即CA组(n = 189)和对照组(n = 87)。肢体导联低电压定义为各肢体导联QRS波群振幅≤0.5 mV。伪梗死图形定义为心电图上至少两个相邻导联出现病理性Q波且无阻塞性冠状动脉疾病。

结果

平均年龄为55±12(15 - 88)岁,168例患者(61%)为男性。CA组房性心律失常(15.9% 对3.4%,P = 0.003)、肢体导联低电压(54.5% 对20.7%,P < 0.001)、房室传导阻滞(14.8% 对1.1%,P = 0.001)和伪梗死图形(40.2% 对4.6%,P < 0.001)比对照组更常见。CA组肢体导联低电压和伪梗死图形同时出现的情况比对照组更常见(28.0% 对2.3%,P < 0.001)。肢体导联低电压和伪梗死图形对CA诊断的敏感性、特异性、阳性预测值和阴性预测值分别为28%、98%、96%和39%。

结论

在CA患者中,肢体导联低电压和伪梗死图形是最常见的心电图表现。房性心律失常和房室传导阻滞是CA患者最常见的心律失常。肢体导联低电压和伪梗死图形同时出现对CA诊断具有较高的特异性和阳性预测值。

相似文献

1
The findings of electrocardiography in patients with cardiac amyloidosis.心脏淀粉样变性患者的心电图检查结果。
Ann Noninvasive Electrocardiol. 2013 Mar;18(2):157-62. doi: 10.1111/anec.12018. Epub 2012 Nov 22.
2
Contribution of Electrocardiogram in the Differentiation of Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy.心电图在心脏淀粉样变性与非梗阻性肥厚型心肌病鉴别诊断中的作用
Int Heart J. 2015;56(5):522-6. doi: 10.1536/ihj.15-005. Epub 2015 Sep 4.
3
Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis.三种主要类型心脏淀粉样变性中心电图 QRS 波低电压的发生率及预后意义。
Am J Cardiol. 2014 Oct 1;114(7):1089-93. doi: 10.1016/j.amjcard.2014.07.026. Epub 2014 Jul 18.
4
[Analysis of clinical and imaging features of cardiac amyloidosis: a multicenter study].[心脏淀粉样变性的临床和影像学特征分析:一项多中心研究]
Nan Fang Yi Ke Da Xue Xue Bao. 2014 Mar;34(3):295-302.
5
Novel electrocardiographic criteria may render possible the more accurate recognition of cardiac amyloidosis.新的心电图标准可能使更准确地识别心脏淀粉样变性成为可能。
ESC Heart Fail. 2024 Apr;11(2):1030-1038. doi: 10.1002/ehf2.14655. Epub 2024 Jan 19.
6
Electrocardiographic features and need for pacemaker in cardiac amyloidosis: Analysis of 58 cases.心电图特征和心脏淀粉样变患者对起搏器的需求:58 例分析。
Med Clin (Barc). 2022 Jul 22;159(2):78-84. doi: 10.1016/j.medcli.2021.09.022. Epub 2022 Jan 21.
7
Electrocardiogram Criteria to Diagnose Cardiac Amyloidosis in Men With a Bundle Branch Block.心电图标准诊断男性束支传导阻滞合并心脏淀粉样变
Am J Cardiol. 2021 May 1;146:89-94. doi: 10.1016/j.amjcard.2021.01.026. Epub 2021 Jan 30.
8
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation.结合心电图和超声心动图检查结果及脑钠肽在早期检测转甲状腺素蛋白基因突变受试者心脏淀粉样变中的应用价值
Am J Cardiol. 2015 Oct 1;116(7):1122-7. doi: 10.1016/j.amjcard.2015.07.008. Epub 2015 Jul 16.
9
Are classic predictors of voltage valid in cardiac amyloidosis? A contemporary analysis of electrocardiographic findings.经典的电压预测指标在心脏淀粉样变性中是否有效?心电图表现的当代分析。
Int J Cardiol. 2016 Jul 1;214:477-81. doi: 10.1016/j.ijcard.2016.04.030. Epub 2016 Apr 8.
10
[Clinical characteristics and cardiac imaging features of patients with cardiac amyloidosis].心脏淀粉样变性患者的临床特征及心脏影像学特征
Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Nov;43(11):960-4.

引用本文的文献

1
T-Amylo Score for the Diagnosis of Transthyretin Cardiac Amyloidosis in Patients With Acute Heart Failure.用于诊断急性心力衰竭患者转甲状腺素蛋白心脏淀粉样变性的T淀粉样蛋白评分
Int J Heart Fail. 2025 Jul 22;7(3):176-183. doi: 10.36628/ijhf.2025.0018. eCollection 2025 Jul.
2
It is Important to be Able to Interpret an ECG Correctly and Quickly: Do We Know How to Perform an ECG?能够正确且快速地解读心电图很重要:我们知道如何进行心电图检查吗?
Acta Cardiol Sin. 2025 Jul;41(4):501-509. doi: 10.6515/ACS.202507_41(4).20250324B.
3
Transthyretin Cardiac Amyloidosis in a Very Elderly Patient With a History of Inferior Myocardial Infarction: A Case Report.一名有下壁心肌梗死病史的高龄患者的转甲状腺素蛋白心脏淀粉样变:病例报告
Cureus. 2025 Feb 8;17(2):e78752. doi: 10.7759/cureus.78752. eCollection 2025 Feb.
4
Clinically meaningful interpretability of an AI model for ECG classification.用于心电图分类的人工智能模型的临床意义可解释性。
NPJ Digit Med. 2025 Feb 17;8(1):109. doi: 10.1038/s41746-025-01467-8.
5
Left bundle branch area pacing in patients with transthyretin cardiac amyloidosis: a case series.转甲状腺素蛋白心脏淀粉样变性患者的左束支区域起搏:病例系列
Eur Heart J Case Rep. 2025 Jan 15;9(1):ytae677. doi: 10.1093/ehjcr/ytae677. eCollection 2025 Jan.
6
Electrocardiographic abnormalities attributable to infiltrative cardiomyopathies: review and prevalence in patients with congestive heart failure.浸润性心肌病所致心电图异常:充血性心力衰竭患者的综述与患病率
Clin Res Cardiol. 2024 Oct 28. doi: 10.1007/s00392-024-02568-2.
7
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management-A Narrative Review.心脏淀粉样变的心电图模式与心律失常:从诊断到治疗管理——一篇叙述性综述
J Clin Med. 2024 Sep 20;13(18):5588. doi: 10.3390/jcm13185588.
8
The value of the electrocardiogram in the recognition of cardiac amyloidosis: a systematic meta-analysis.心电图在心脏淀粉样变性识别中的价值:系统荟萃分析。
BMC Cardiovasc Disord. 2024 Sep 13;24(1):488. doi: 10.1186/s12872-024-04143-z.
9
Advances in the Diagnosis and Management of Cardiac Amyloidosis: A Literature Review.心脏淀粉样变的诊断与管理进展:文献综述
Cardiol Res. 2024 Aug;15(4):211-222. doi: 10.14740/cr1664. Epub 2024 Jul 18.
10
Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis.转甲状腺素蛋白心脏淀粉样变的诊断方法与治疗策略的最新进展
World J Cardiol. 2024 Jul 26;16(7):370-379. doi: 10.4330/wjc.v16.i7.370.

本文引用的文献

1
Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis.心电图与超声心动图联合指标在经活检证实的原发性心脏淀粉样变性诊断中的应用价值。
Ann Noninvasive Electrocardiol. 2011 Jan;16(1):25-9. doi: 10.1111/j.1542-474X.2010.00403.x.
2
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.系统性心脏淀粉样变:3种主要类型的疾病特征与临床病程
Circulation. 2009 Sep 29;120(13):1203-12. doi: 10.1161/CIRCULATIONAHA.108.843334. Epub 2009 Sep 14.
3
Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis.经心内膜心肌活检证实的心脏淀粉样变性患者的功能状态、心电图和超声心动图参数与死亡率的比较。
Am J Cardiol. 2009 May 15;103(10):1429-33. doi: 10.1016/j.amjcard.2009.01.361. Epub 2009 Apr 1.
4
Evaluation and management of the cardiac amyloidosis.心脏淀粉样变性的评估与管理
J Am Coll Cardiol. 2007 Nov 27;50(22):2101-10. doi: 10.1016/j.jacc.2007.08.028. Epub 2007 Nov 13.
5
Current treatment in cardiac amyloidosis.心脏淀粉样变性的当前治疗方法。
Curr Treat Options Cardiovasc Med. 2006 Dec;8(6):468-73. doi: 10.1007/s11936-006-0035-5.
6
Amyloidosis and the heart: a comprehensive review.淀粉样变性与心脏:全面综述
Arch Intern Med. 2006 Sep 25;166(17):1805-13. doi: 10.1001/archinte.166.17.1805.
7
Diagnosis and management of the cardiac amyloidoses.心脏淀粉样变的诊断与管理
Circulation. 2005 Sep 27;112(13):2047-60. doi: 10.1161/CIRCULATIONAHA.104.489187.
8
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.免疫球蛋白轻链淀粉样变性(AL)中器官受累及治疗反应的定义:2004年4月18 - 22日于法国图尔举行的第10届国际淀粉样变性和淀粉样变研讨会的共识意见
Am J Hematol. 2005 Aug;79(4):319-28. doi: 10.1002/ajh.20381.
9
Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.原发性系统性淀粉样变性及经活检证实的心脏受累的心电图表现。
Am J Cardiol. 2005 Feb 15;95(4):535-7. doi: 10.1016/j.amjcard.2004.10.028.
10
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.经活检证实的心脏淀粉样变的无创诊断。
J Am Coll Cardiol. 2004 Feb 4;43(3):410-5. doi: 10.1016/j.jacc.2003.08.043.